LEXARIA BIOSCIENCE CORP. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
LEXARIA BIOSCIENCE CORP. (LEXX) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 12.49 million shares for the 9-month period ending 2026-05-31, per its 10-Q filed 2026-07-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-07-13
- LEXARIA BIOSCIENCE CORP. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-11-30 was 11.54M shares, a 191.18% increase year-over-year.
- LEXARIA BIOSCIENCE CORP. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-11-30 was 3.96M shares.
- LEXARIA BIOSCIENCE CORP. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 8.78M shares, a 27.72% increase from fiscal 2024.
- LEXARIA BIOSCIENCE CORP. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 6.88M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2026-05-31 | 12.49M shares 10-Q · filed 2026-07-13 | |||
| 2026-02-28 | 12.57M shares 10-Q · filed 2026-04-13 | |||
| 2025-11-30 | 11.54M shares 10-Q · filed 2026-01-13 | |||
| 2025-08-31 | 8.78M shares 10-K · filed 2025-11-28 | |||
| 2025-05-31 | 8.78M shares 10-Q · filed 2026-07-13 | |||
| 2025-02-28 | 8.63M shares 10-Q · filed 2026-04-13 | |||
| 2024-11-30 | 3.96M shares 10-Q · filed 2026-01-13 | |||
| 2024-08-31 | 6.88M shares 10-K · filed 2025-11-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |